Bristol-Myers recalls Coumadin blood thinner

May 02, 2011

(AP) -- Bristol-Myers Squibb Co. says it is recalling one production lot of its blood thinner Coumadin after finding an oversize tablet.

The company says it tested a returned bottle of Coumadin and found that one tablet was more potent than expected. An excessive dose of Coumadin, or , could create an increased risk of bleeding. The recall affects 5-milligram Coumadin tablets with an expiration date of Sept. 30, 2012. The production lot is number 9H49374A.

The New York drugmaker says patients taking 5-milligram tablets should not stop taking them, but should talk to their pharmacist to find out if their prescription was filled with that have been recalled.

Explore further: Supercomputers link proteins to drug side effects

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Study: New blood thinner works as well as Coumadin

Nov 15, 2010

(AP) -- A study finds that a new and easier-to-use blood thinner prevents strokes in people with a common heart rhythm problem as well as Coumadin does, and without an increase in bleeding or side effects.

Microsoft to release a tablet OS in 2012

Mar 04, 2011

(PhysOrg.com) -- Microsoft has finally decided to join the tablet OS market. Following in the grand tradition of Kinect (motion controls for video games, which came out after the Nintendo Wii sported them) ...

How does the color of a pill affect its efficacy?

Nov 15, 2010

According to recent research the color, shape, taste and even name of a tablet or pill can have an effect on how patients feel about their medication. Choose an appropriate combination and the placebo effect gives the pill ...

Recommended for you

Supercomputers link proteins to drug side effects

11 hours ago

New medications created by pharmaceutical companies have helped millions of Americans alleviate pain and suffering from their medical conditions. However, the drug creation process often misses many side ...

No added benefit proven for umeclidinium/vilanterol in COPD

18 hours ago

The drug combination umeclidinium/vilanterol (trade name Anoro) has been approved since May 2014 for adults with chronic obstructive pulmonary disease (COPD). In an early benefit assessment pursuant to the Act on the Reform ...

User comments : 0